MENU
+Compare
ELAB
Stock ticker: NASDAQ
AS OF
Dec 3 closing price
Price
$5.12
Change
-$0.26 (-4.83%)
Capitalization
3.81M

ELAB PMGC Holdings Inc Forecast, Technical & Fundamental Analysis

PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation... Show more

ELAB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ELAB with price predictions
Nov 28, 2025

ELAB in downward trend: price dove below 50-day moving average on November 12, 2025

ELAB moved below its 50-day moving average on November 12, 2025 date and that indicates a change from an upward trend to a downward trend. In of 12 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ELAB as a result. In of 34 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for ELAB crossed bearishly below the 50-day moving average on November 12, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELAB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ELAB entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ELAB's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 23 cases where ELAB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ELAB just turned positive on November 28, 2025. Looking at past instances where ELAB's MACD turned positive, the stock continued to rise in of 11 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ELAB advanced for three days, in of 74 cases, the price rose further within the following month. The odds of a continued upward trend are .

ELAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.449) is normal, around the industry mean (27.312). P/E Ratio (0.013) is within average values for comparable stocks, (52.442). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.886). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (5.025) is also within normal values, averaging (321.020).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ELAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
ELAB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
120 Newport Center Drive
Phone
+1 866 794-4940
Employees
18
Web
https://www.elevailabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GBFH32.820.29
+0.89%
Gbank Financial Holdings Inc
NXT86.59-0.85
-0.97%
Nextracker
ZLAB19.51-0.37
-1.86%
Zai Lab Limited
TVGN0.39-0.02
-4.53%
Tevogen Bio Holdings
LGHL6.46-0.78
-10.77%
Lion Group Holding Ltd.

ELAB and Stocks

Correlation & Price change

A.I.dvisor tells us that ELAB and LXRX have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELAB and LXRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAB
1D Price
Change %
ELAB100%
-0.94%
LXRX - ELAB
25%
Poorly correlated
-1.10%
MTNB - ELAB
25%
Poorly correlated
+3.77%
EDSA - ELAB
24%
Poorly correlated
+1.17%
LTRN - ELAB
21%
Poorly correlated
-0.28%
TGTX - ELAB
21%
Poorly correlated
-3.32%
More